[Event Report] The Fourth Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC) (December 14, 2020)
- Home >
- Information >
- Event >
- [Event Report] The Fourth Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC) (December 14, 2020)
AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) held The Fourth Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC).
At this fourth meeting, participants from the public and private sectors discussed ways to advocate for our recommendations on the creation of a sustainable research and development (R&D) environment for antimicrobials in Japan.
In light of the situation with novel coronavirus, this meeting was carried out primarily online. On-site participants were encouraged to keep a safe physical distance from each other.
■Overview
Date and time: Monday, December 14, 2020
Organizer: AMR Alliance Japan (Secretariat: Health and Global Policy Institute)
■Program
Greetings and Opening Remarks
Kazuhiro Tateda (President, The Japanese Association for Infectious Diseases / President, The Japanese Society for Clinical Microbiology / Professor, Department of Microbiology and Infectious Diseases, Toho University)
Ryoji Noritake (CEO, Board Member, Health and Global Policy Institute (AMR Alliance Japan Secretariat))
Report on The 7th NIKKEI FT Communicable Diseases Conference and Advocacy Plan Proposed by the Secretariat:
Matt McEnany (AMR Alliance Japan Secretariat/Senior Manager, Health and Global Policy Institute)
Discussion
Chair:
Kazuhiro Tateda (President, The Japanese Association for Infectious Diseases / President, The Japanese Society for Clinical Microbiology / Professor, Department of Microbiology and Infectious Diseases, Toho University)
• Advocacy Plan
• Timelines
• Target groups
Facilitator:
Yui Kohno (AMR Alliance Japan Secretariat/Associate, Health and Global Policy Institute)
Closing Remarks:
Mitsuru Miyata (Representative Director, Healthcare Innovation Co.,Ltd./ Representative Director, Miyata Research Institute Co., Ltd.)
■Related events held as part of the “The Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)” project in and after FY2019 (chronological order)
January 22, 2020 The First Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
September 23, 2020 The Third Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
November 7, 2020 The 7th NIKKEI FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC)